Effect of chronic kidney disease on the association between hyperuricemia and new-onset hypertension in the general Japanese population: ISSA-CKD study.


Journal

Journal of clinical hypertension (Greenwich, Conn.)
ISSN: 1751-7176
Titre abrégé: J Clin Hypertens (Greenwich)
Pays: United States
ID NLM: 100888554

Informations de publication

Date de publication:
12 2021
Historique:
revised: 29 09 2021
received: 27 07 2021
accepted: 11 10 2021
pubmed: 23 11 2021
medline: 1 1 2022
entrez: 22 11 2021
Statut: ppublish

Résumé

We aimed to investigate the association between serum uric acid (SUA) level and development of hypertension as well as the interaction effect of chronic kidney disease (CKD) on this relationship in the general Japanese population. We included 7895 participants aged ≥30 years from the ISSA-CKD study, a population-based retrospective cohort study that used annual health check-up data of residents from Iki Island, Japan. After the exclusion of 1881 with l < 1-year follow-up, 2812 with hypertension at baseline, and 165 with missing information on SUA, a total of 3037 participants were enrolled in this analysis. Participants were divided into four groups according to the quartiles of SUA level at baseline, and multivariable-adjusted hazard ratios for new-onset hypertension were calculated. Stratified analyses were performed for each subgroup (defined by sex, age, alcohol intake, and CKD) to assess the interaction effects. During a mean follow-up period of 4.4 years, 943 participants developed hypertension. The first quartile group was set as the reference group, and the multivariable-adjusted hazard ratios (95% confidence interval) for new-onset hypertension were 1.11 (0.90-1.36) in the second quartile, 1.25 (1.02-1.54) in the third quartile, and 1.35 (1.07-1.70) in the fourth quartile compared with those in the reference group (p = .007 for trend). The stratified analyses showed that the association between SUA and hypertension was significantly stronger in participants with CKD than in those without CKD (p = .035 for interaction). SUA level is an independent risk factor for new-onset hypertension. This tendency was significantly stronger in participants with CKD.

Identifiants

pubmed: 34806282
doi: 10.1111/jch.14390
pmc: PMC8696210
doi:

Substances chimiques

Uric Acid 268B43MJ25

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2071-2077

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC.

Références

Curr Hypertens Rep. 2016 Oct;18(10):74
pubmed: 27696189
Diabetol Int. 2020 Jul 24;11(3):165-223
pubmed: 32802702
Intern Med. 2020 Jan 15;59(2):175-180
pubmed: 31554753
Am J Kidney Dis. 2018 Jun;71(6):851-865
pubmed: 29496260
BMC Nephrol. 2011 Jul 02;12:31
pubmed: 21722384
Hypertens Res. 2014 Aug;37(8):785-9
pubmed: 24671018
Am J Kidney Dis. 2009 Jun;53(6):982-92
pubmed: 19339088
Hypertens Res. 2019 Sep;42(9):1235-1481
pubmed: 31375757
Am J Physiol Renal Physiol. 2017 Jun 1;312(6):F992-F997
pubmed: 28249837
Nephrol Dial Transplant. 2012 May;27(5):1831-5
pubmed: 21940488
Lancet. 2016 Aug 20;388(10046):761-75
pubmed: 27431356
Prev Med. 2016 Sep;90:201-6
pubmed: 27404578
Clin Exp Nephrol. 2021 Jul;25(7):751-759
pubmed: 33689045
J Clin Med Res. 2020 Jul;12(7):431-435
pubmed: 32655737
J Clin Hypertens (Greenwich). 2021 Dec;23(12):2071-2077
pubmed: 34806282
J Atheroscler Thromb. 2018 Sep 1;25(9):846-984
pubmed: 30135334
J Am Soc Nephrol. 2008 Dec;19(12):2407-13
pubmed: 18799720
J Hypertens. 2018 Jul;36(7):1499-1505
pubmed: 29746372
Kidney Int. 2005 Jan;67(1):237-47
pubmed: 15610247
Hypertension. 2018 Jan;71(1):78-86
pubmed: 29203632
J Hum Hypertens. 2019 Dec;33(12):873-878
pubmed: 31113986
PLoS One. 2021 Feb 2;16(2):e0246304
pubmed: 33529192
J Hum Hypertens. 2014 Sep;28(9):529-34
pubmed: 24430703
Clin Exp Nephrol. 2020 Oct;24(10):919-926
pubmed: 32577942
Circ J. 2002 Nov;66(11):987-92
pubmed: 12419927
PLoS One. 2014 Dec 01;9(12):e114259
pubmed: 25437867
J Biol Chem. 2008 Oct 3;283(40):26834-8
pubmed: 18701466
Am J Kidney Dis. 2019 Jul;74(1):120-131
pubmed: 30898362
Hypertension. 2005 Jan;45(1):28-33
pubmed: 15569852
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
BMJ. 2017 Jun 7;357:j2376
pubmed: 28592419
Hypertens Res. 2020 May;43(5):442-449
pubmed: 31776471

Auteurs

Miki Kawazoe (M)

Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Shunsuke Funakoshi (S)

Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Shintaro Ishida (S)

Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Chikara Yoshimura (C)

Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Department of Respiratory Medicine, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Atsushi Satoh (A)

Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Toshiki Maeda (T)

Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Masayoshi Tsuji (M)

Department of Lifestyle and Welfare Information, Kindai University Kyushu Junior College, Fukuoka, Japan.

Soichiro Yokota (S)

Department of Internal Medicine, Faculty of Medicine, Fukuoka University, Division of Nephrology and Rheumatology, Fukuoka, Japan.

Kazuhiro Tada (K)

Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Department of Internal Medicine, Faculty of Medicine, Fukuoka University, Division of Nephrology and Rheumatology, Fukuoka, Japan.

Koji Takahashi (K)

Department of Internal Medicine, Faculty of Medicine, Fukuoka University, Division of Nephrology and Rheumatology, Fukuoka, Japan.

Kenji Ito (K)

Department of Internal Medicine, Faculty of Medicine, Fukuoka University, Division of Nephrology and Rheumatology, Fukuoka, Japan.

Tetsuhiko Yasuno (T)

Department of Internal Medicine, Faculty of Medicine, Fukuoka University, Division of Nephrology and Rheumatology, Fukuoka, Japan.

Hideyuki Fujii (H)

Department of Endocrinology and Diabetes Mellitus, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Shota Okutsu (S)

Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Department of General Medicine, Fukuoka University Hospital, Fukuoka, Japan.

Shigeaki Mukobara (S)

Nagasaki Prefecture Iki Hospital, Nagasaki, Japan.

Daiji Kawanami (D)

Department of Endocrinology and Diabetes Mellitus, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Shigeki Nabeshima (S)

Department of General Medicine, Fukuoka University Hospital, Fukuoka, Japan.

Seiji Kondo (S)

Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Kosuke Masutani (K)

Department of Internal Medicine, Faculty of Medicine, Fukuoka University, Division of Nephrology and Rheumatology, Fukuoka, Japan.

Hisatomi Arima (H)

Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH